Enhancing radiotherapy for lung cancer using immunoadjuvants delivered in situ from new design radiotherapy biomaterials: a preclinical study.
about
Following the Preclinical Data: Leveraging the Abscopal Effect More Efficaciously.Nanotechnology: Advancing the translational respiratory research.Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences.Using immunotherapy to boost the abscopal effect.Cancer Immunotherapy: From local to global.Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants.
P2860
Enhancing radiotherapy for lung cancer using immunoadjuvants delivered in situ from new design radiotherapy biomaterials: a preclinical study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Enhancing radiotherapy for lun ...... aterials: a preclinical study.
@en
type
label
Enhancing radiotherapy for lun ...... aterials: a preclinical study.
@en
prefLabel
Enhancing radiotherapy for lun ...... aterials: a preclinical study.
@en
P2093
P2860
P356
P1476
Enhancing radiotherapy for lun ...... materials: a preclinical study
@en
P2093
Neeharika Sinha
Sayeda Yasmin-Karim
Wilfred Ngwa
P2860
P304
P356
10.1088/1361-6560/61/24/N697
P577
2016-12-02T00:00:00Z